Opportunities and Challenges in the Delivery of mRNA-Based Vaccines

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 2×

Liposome: classification, preparation, and applications

Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati‐Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,648

Mechanisms of type-I- and type-II-interferon-mediated signalling

Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,631

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474

Toxicity of cationic lipids and cationic polymers in gene delivery

Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286

The alphaviruses: gene expression, replication, and evolution.

Strauss, J. H., & Strauss, E. G. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.3.491-562.1994 · Cited by 2,221

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819

Perfluoroalkyl Chain-Modified Artificial Viral Capsid for Enhanced Intracellular Delivery of mRNA

Ghosh, A., Yamamoto, Y., Wada, M., Inaba, H., Aikawa, K., Ota, Y., Okazoe, T., & Matsuura, K. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00477 · Cited by 4

Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods

Gu, R., Si, D., Lei, D., Xie, X., Li, Y., & Wen, H. (2026) · MedComm · doi:10.1002/mco2.70612 · Cited by 6

Tailoring nanovectors for optimal neoantigen vaccine efficacy

Zheng, Y., Wang, B., Cai, Z., Lai, Z., Yu, H., Wu, M., Liu, X., & Zhang, D. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02547d · Cited by 4

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

Lokras, A. G., Baghel, S. S., Jensen, R. F., Thakur, A., Franzyk, H., Thofte, O., Herrera‐Barrera, M., Landry, M. R., Ongun, M., Tami, A., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202505627 · Cited by 5

Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium

Canjuga, D., Steinle, H., Mayer, J., Uhde, A.-K., Klein, G., Wendel, H. P., Schlensak, C., & Avci‐Adali, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061194 · Cited by 4

Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation

Słomka, S., Zięba, P., Rosiak, O., & Piekarska, A. (2023) · Vaccines · doi:10.3390/vaccines11101625 · Cited by 7

Evaluation of the effects of MERCK, MODERNA, PFIZER/BioNTech, and JANSSEN COVID-19 vaccines on vaccinated people: A metadata analysis

Al‐Rousan, N., & Al-Najjar, H. M. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101564 · Cited by 5

Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo

Zhang, Y., Tian, C., Yu, X., Yu, G., Han, X., Wang, Y., Zhou, H., Zhang, S., Li, M., Yang, T., et al. (2024) · Vaccines · doi:10.3390/vaccines12121315 · Cited by 4

Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity

Hu, J., Cao, H., Luan, N., Zhang, X., Liang, B., Gao, D., Lei, Z., Bi, Y., & Liu, C. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127241 · Cited by 4

Inside the cell: Approaches to evaluating mRNA internalization and trafficking

Runzer, C. D. T., Plank, C., van Griensven, M., & Balmayor, E. R. (2025) · Methods · doi:10.1016/j.ymeth.2025.06.006 · Cited by 5

mRNA vaccines: Why and how they should be modified

Feliciello, I., & Procino, A. (2021) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2021.10072 · Cited by 3

Synthetic mRNA for ex vivo therapeutic applications

Nakanishi, H., & Itaka, K. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100447 · Cited by 4

Lipid Nanoparticle-Mediated Delivery of Therapeutic and Prophylactic mRNA: Immune Activation by Ionizable Cationic Lipids

Ongun, M., Lokras, A. G., Foged, C., & Thakur, A. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_11 · Cited by 4

Alphaviruses in cancer immunotherapy

Lundstrom, K. H. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.03.011 · Cited by 4

Recent Updates on Peptide Molecules in Drug and Vaccine Development

Sarfaraz, M., Anjum, F., Zahra, D., Maqsood, A., & Ashfaq, U. A. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230717121632 · Cited by 6

Engineered chimeric T7 RNA polymerase improves salt tolerance and reduces dsRNA impurity generation during in vitro transcription of mRNA

Sanjeev, A., Reiss, C. W., Politi, J., Beuning, P. J., & Cheng, C. J. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1124 · Cited by 3

Advancements in breast cancer mRNA vaccines: Current development and future prospects

Zheng, W., Chen, W., Hutvágner, G., Rangel, L., & Deng, W. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189515 · Cited by 3

Electrochemical and spectrophotometric investigation of DNA interactions with TURKOVAC and Pfizer-BioNTech vaccines: Implications for biosensor sensitivity

Aslan, M., & Levent, A. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345060 · Cited by 3

Synergizing immunity: lipid nanoparticle-mediated mRNA and gene delivery as a next-gen paradigm in cancer immunotherapy

Roy, A. A., Jain, N., Pokale, R., Madhusoodanan, G., Mukharya, A., Farhana, S. A., Rao, B. S. S., Goda, J. S., & Mutalik, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126862 · Cited by 4

Precision breast oncology: molecular insights and transformative clinical strategies

Chauhan, B., Kumar, D., Ahmad, A., Haque, Z., Baig, M. S., Choudhary, N., Tanwar, R., Sophia, A., Alam, M. I., Webster, T. J., et al. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101242 · Cited by 5

Precision Engineering of Extracellular Vesicles as Programmable Carriers for mRNA Therapeutics

Yoon, H., Lee, G., Jo, J., Koo, J., Kim, E., Choi, H. J., Jung, S., Shin, Y., Oh, K. T., & Lim, C. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s595161 · Cited by 3

In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery

Miliotou, Α. N., Pappas, I. S., Vizirianakis, I. S., & Papadopoulou, L. C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_10 · Cited by 3

Critical applications and prospects of RNA modification in mRNA vaccines

Liu, C., Peng, J., Zhang, M., Xiang, H., & Yi, C. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0800 · Cited by 2

Cationic cycloamylose based nucleic acid nanocarriers

Prasher, P., Sharma, M., Agarwal, V., Singh, S. K., Gupta, G., Dureja, H., & Dua, K. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111000 · Cited by 3

A Comprehensive Review on Transformative Role of Polymer in Advancing Pharmaceutical Drug Delivery System

Bole, S. S., Kothawade, S. N., Wagh, V. S., & Pande, V. V. (2024) · Current Applied Polymer Science · doi:10.2174/0124522716311647240613050008 · Cited by 3

Spike protein-related proteinopathies: A focus on the neurological side of spikeopathies

Posa, A. (2025) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2025.152662 · Cited by 3

Non-viral mRNA cystic fibrosis therapies and their ongoing clinical trials

Gill, N. A., Fung, V., VanKeulen‐Miller, R., Narasipura, E. A., & Fenton, O. S. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2586172 · Cited by 3

Grand Challenges in Vaccine Delivery: Lessons Learned From the COVID-19 Vaccine Rollout

Foged, C. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.964298 · Cited by 3

LOSS OF AN ABUNDANT QUANTITY OF RIBONUCLEIC ACID DURING MINI COLUMN ISOLATION METHOD

Genekam Biotechnology AG, D. D., & Sudhir, B. (2023) · Biotechnologia Acta · doi:10.15407/biotech16.03.065 · Cited by 3

mRNA vaccines in gastric cancer: How close are we?

Portillo‐Miño, J. D., Bettin-Gonzalez, D., & Coral, F. A. M. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacune.2024.02.012 · Cited by 3

Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses

Albadr, R. J., Sameer, H. N., Athab, Z. H., Adil, M., Yaseen, A., & Allela, O. Q. B. (2025) · Biological Procedures Online · doi:10.1186/s12575-025-00269-2 · Cited by 4

Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma

Pan, Y., Chen, R., Lv, X., Wang, Y., & Zhang, H. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01911-y · Cited by 4

Latest Trends in Nucleic Acids’ Engineering Techniques Applied to Precision Medicine

Pereira, G. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2716-7_2 · Cited by 3

mRNA-based COVID-19 vaccines: a new age

Martínez-Espinosa, R. R., & Ramírez-Vélez, G. (2021) · Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare · doi:10.36105/psrua.2021v1n2.03 · Cited by 2

A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease

Wu, Y., & Song, H. X. (2022) · Life · doi:10.3390/life12010130 · Cited by 6

Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder

Contentti, E. C., & Correale, J. D. (2025) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2025.2470706 · Cited by 3

Endogenous antigen processing promotes mRNA vaccine CD4 + T cell responsesPreprint

Rood, J. E., Yoon, S. K., Heard, M. K., Carro, S. D., Hedgepeth, E. J., O'Mara, M. E., Hogan, M. J., Le, N., Muramatsu, H., Lam, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642674 · Cited by 3

Innovation in mRNA Vaccines and RNAi via Protein Nanocages

Ahmadivand, S. (2025) · Vaccines · doi:10.3390/vaccines13060653 · Cited by 2

Potential of MRNA vaccines for mpox prevention: current evidence and future directions

Abdul‐Rahman, T., Ogungbemi, E. F., Ajetunmobi, O. A., Thaalibi, H. I., Ikele, C. G., Gautam, G., Olanrewaju, O. F., Roy, P., Adebayo, A. A., Mojeed, M. A., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003558 · Cited by 3

Piercing the future of vaccination: the revolutionary role of microneedle-based systems in healthcare advancements

Koçer, A. T., Durasi, E., Kuscu, E., Amasya, H., Maden, H., Ay, H. F., Çalık, H., Memis, H., Coksu, I., Surgit, N., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127612 · Cited by 2

Elastin-like peptides for efficient and safe delivery of mRNA

Li, F., Wang, Q., Wang, T., Xiong, C., Chen, Z., Ouyang, H., Lou, X., Xia, F., Wang, S., Wu, M., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114337 · Cited by 2

One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development

Ona, N. A., Zhang, D., Lindesmith, L. C., Park, W., Meshanni, J. A., Berkihiser, S., Vasserman, J. A., Toshtzar, S., Moore, N. C., Williams, B., et al. (2026) · Science Advances · doi:10.1126/sciadv.adv1554 · Cited by 2

The current landscape of mRNA therapy and the strategies for mRNA purification and dsRNA removal

Liu, J., Zang, J., Jing-Ru, X., Ran, X., Su, M., Zhang, W.-M., Ge, Z.-W., Sun, Q.-Y., & Ding, L. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01277-4 · Cited by 2

Nanovaccines delivery approaches against infectious diseases

Tabarzad, M., Mohit, E., & Ghorbani‐Bidkorbeh, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90792-7.00002-6 · Cited by 2

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Xiao, Q., Liu, Y., Zhang, D., Li, C., Yang, Q., Lu, D., Zhang, W., Rosenecker, J., Zou, Q., Li, Y., et al. (2022) · Journal of Visualized Experiments · doi:10.3791/64288 · Cited by 3

Preparation of Messenger RNA-Loaded Nanomedicine Applied on Tissue Engineering and Regenerative Medicine

Tsou, H., Chang, C.-C., Maeda, T., & Lin, C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_18 · Cited by 2

Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields

Baghaie, L., Leroy, F., Sheikhi, M., Jafarzadeh, A., Szewczuk, M. R., & Sheikhi, A. (2023) · Viruses · doi:10.3390/v15102079 · Cited by 2

Circulating CTLA-4 Level and CTLA-4 rs733618 Gene Polymorphism Role in Immunological Response to Pfizer BioNTech (BNT162b2) COVID-19 Vaccine in Iraq

Ezzaldeen, S. S., Kadhim, H. S., & Abdulameer, A. J. (2023) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.17.4.474 · Cited by 2

mRNA vaccines in gastric cancer: How close are we?

Portillo‐Miño, J. D., Bettin-Gonzalez, D., & Coral, F. A. M. (2023) · Vacunas · doi:10.1016/j.vacun.2023.10.006 · Cited by 2

Progress in mRNA cancer vaccine research, current limitations, application and future

Zeng, X. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/20/20230742 · Cited by 2

Biosafety and regulatory issues of RNA therapeutics

Thị, H. V., Thi, L.-A. N., Tang, T. L., & Chu, D. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.008 · Cited by 2

Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations and Applications

Sharma, T., Babu, M. A., Jain, A., & Sharma, D. (2024) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812284202231228095045 · Cited by 2

Therapeutic potential for mRNA-based IGF-I regenerative therapy

Anderson, C. D. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102143 · Cited by 2

mRNA therapeutics in diseases: Light inspect into a new horizon

Li, Y. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/44/20240857 · Cited by 2

mRNA vaccine delivery strategies for cancer therapy

Zhang, H., Zhang, H., Xu, B., & Liu, H. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0670 · Cited by 2

System Theoretic Methods in Drug Discovery and Vaccine Formulation: Review and Perspectives

Sharma, A., Hsiao, Y.-C., & Dutta, A. (2025) · Drugs and Drug Candidates · doi:10.3390/ddc4030028 · Cited by 2

RNA-based vaccines against SARS-CoV-2

Rosales‐Mendoza, S., Wong-Arce, A., & Betancourt-Mendiola, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90248-9.00014-0 · Cited by 2

RECENT APPROACHES IN DEVELOPMENT OF RNA AND DNA BASED VACCINES

(2022) · International Journal of Veterinary Science · doi:10.47278/book.ahp/2022.52 · Cited by 2

Generating Human Induced Pluripotent Stem Cell Via Low-Dose Polyethylenimine-Mediated Transfection: An Optimized Protocol

Shayestehfar, M., Farahi, S., Azar, B. K. Y., Memari, A. H., Baluchnejadmojarad, T., & Faghihi, F. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0331 · Cited by 2

Hepatocyte-Directed Delivery of Lipid-Encapsulated Small Interfering RNA

Morán, L., Woitok, M. M., Bartneck, M., & Cubero, F. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2557-6_6 · Cited by 2

Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic

Liu, C.-H., Huang, H.-Y., Tu, Y. F., Lai, W.-Y., Wang, C.-L., Sun, J., Chien, Y., Lin, T.-W., Lin, Y.-Y., Chien, C., et al. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000461 · Cited by 2

Engineering degradation-resistant messenger RNAs in yeastPreprint

Franklin, A. L., MacFadden, A., Kieft, J. S., Hesselberth, J. R., & Chapman, E. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.25.169177 · Cited by 2

Low-dose Polyethylenimine-Mediated Transfection to Generate Human Induced Pluripotent Stem Cell: an optimized protocolPreprint

Shayestehfar, M., Farahi, S., Azar, B. K. Y., Memari, A. H., Baluchnejadmojarad, T., & Faghihi, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1314449/v1 · Cited by 2

Nanoparticles for mRNA-based cancer immunotherapy

Pahwa, R., Sharma, G., Panwar, R., & Mishra, N. (2025) · Advances in immunology · doi:10.1016/bs.ai.2024.10.012 · Cited by 1

Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19

Kole, E. B., Jadhav, K., Singh, R., Verma, R. K., Chatterjee, A., & Naik, J. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2025053265 · Cited by 1

Photothermal/GSH-dual-responsive organic quantum dots enabling traceable DNA delivery

Tu, Y., Wang, M., Zheng, Y., Zeng, D., Liu, H., Di, X., Chen, X., & Liu, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147542 · Cited by 2

Cross-Priming and Cross-Tolerance After Intramuscular mRNA Vaccination for Viral Infections: Feasibility and Implications

Mueller, S. (2025) · Life · doi:10.3390/life15101575 · Cited by 1

Messenger RNA vaccines for tuberculosis prevention: A narrative review of current research and prospects

Saeed, T. S., Saeed, M. R., Abdullah, M. F., Qureshi, M. S., Saeed, A., Munawar, S., Saifullah, M., & Rana, I. (2025) · World Journal of Pharmacology · doi:10.5497/wjp.v14.i1.110200 · Cited by 1

Fimbriae potentiate Aggregatibacter actinomycetemcomitans for periodontal disease

Fu, Y., Pan, Q., & van Dijl, J. M. (2026) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2026.100566 · Cited by 1

Cellular Immune Response Induced by mRNA Vaccines Against SARS‐CoV‐2

Tovar, V., Sánchez, I. P., Rugeles, M. T., Taborda, N. A., & Hernández, J. C. P. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70375 · Cited by 1

mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules

Kakroudi, M. H., Rezvanimehr, A., Zolfaghari, K., Baghaei-Shiva, G., Abbasi, H., Pourashory, M., Yazdanpanah, N., Saleki, K., & Rezaei, N. (2026) · Discover Oncology · doi:10.1007/s12672-026-04811-w · Cited by 1

Scalable Engineering of Bio‐Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient‐Derived Models

Godbole, N., Lai, A., Quinn, A., Gillard, M., Guanzon, D., Scholz‐Romero, K., Salas-Burgos, A., Lillo-Dapremont, B., Lourie, R., Chetty, N., et al. (2026) · Advanced Science · doi:10.1002/advs.75415 · Cited by 1

mRNA vaccines for viral diseases: mechanism, advances, and future perspective

Chakraborty, B., & Singh, T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11856-1 · Cited by 1

Review of advances and future directions in mRNA-based therapeutics for malaria mitigation

Enyi, E. O., & Umeyor, I. C. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08662-6 · Cited by 1

Hyperbranched poly(β-amino ester)s-mediated delivery of engineered Klotho mRNA rescues senescence and restores cellular homeostasis in aged and Klotho deficient iMSCs

Zaidi, S. A. A., Yong, H., Padhiar, A. A., Faqeer, A., Song, J., He, L., Zaidi, S. S. A., Khan, N., Zhou, D., & Zhou, G. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02166-x · Cited by 1

Synergistic co-delivery approaches for next-generation mRNA cancer immunotherapy

Khan, M. K., Hussain, I., Jiahui, L., Zimeng, L., Chenqi, J., Yuxin, Y., Tingyi, Y., Ke, D., Khalil, M. I. K., Hussain, Z., et al. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100928 · Cited by 1

Structural characterization of Lysimachia christinae acidic polysaccharides and investigation of its adjuvant efficacy for mRNA vaccines

Tian, C., Nie, J., Chen, Y., Dong, C., Ji, M., Liu, Y., Nie, J., Zhang, X., Sun, J., Gang, J., et al. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116854 · Cited by 1

Genetic engineering approaches to the development of modern therapeutics

Григорьевна, Б. Е., Копейкин, П. М., & Tagaev, A. A. (2020) · Medical academic journal · doi:10.17816/maj34092 · Cited by 1

mRNA Vaccine Review against COVID-19 with Potential Applications to Improve Efficacy and Targeting

Iqbal, M. S., & Mousa, S. A. (2021) · International Journal of Vaccines and Immunization · doi:10.16966/2470-9948.124 · Cited by 1

Transient Pneumonitis as a Possible Adverse Reaction to the BNT162b2 COVID-19 mRNA Vaccine in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature

Ohkubo, Y., Ohmura, S., Ishihara, R., & Miyamoto, T. (2022) · Case Reports in Rheumatology · doi:10.1155/2022/3124887 · Cited by 1

Role of Nanotechnology in Diagnosing, Safeguarding, and Treating COVID-19

de Silva, R. M., Hulugalla, K., Ranasinghe, P. R. P., Williams, G. R., & de Silva, K. M. N. (2023) · Maǧallaẗ ǧāmiʿaẗ al-Sulṭān Qābūs li-l-ʿulūm/Sultan Qaboos University journal for science · doi:10.53539/squjs.vol28iss1pp25-41 · Cited by 1

Drug Delivery Systems: Lipid Nanoparticles Technology in Clinic

Andhari, S. S., Gupta, R., & Khandare, J. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_12 · Cited by 1

Rare presentation of COVID-19 vaccine-induced myocarditis: A case report

Rehman, M. A. U., Ilyas, H., Iqbal, J., Huda, S. H., Akram, H., Mohamed, S., & Kuwari, M. A. (2023) · Journal of emergency medicine, trauma & acute care · doi:10.5339/jemtac.2023.35 · Cited by 1

Real-Life Experience in the Efficacy and Safety of COVID-19 Vaccination in Patients with Advanced Cirrhosis

Hanafy, A. S., Embaby, A., Salem, S. M., Behiry, A., Ebrahim, H. A., Elkattawy, H. A., Abed, S. Y., Almadani, M. E., & El‐Sherbiny, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247578 · Cited by 1

Approaches to Improve the Immunogenicity of Plasmid DNA-Based Vaccines against COVID-19

Borgoyakova, M. B., Volosnikova, E. A., Ilyichev, A. A., & Карпенко, Л. И. (2023) · Genetics. · doi:10.5772/intechopen.113945 · Cited by 1

Reagents and their delivery systems in CRISPR/Cas

Khan, S., Zafar, H., & Ahmad, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18444-4.00002-8 · Cited by 1

Navigating the horizon of mRNA vaccines: Tracing their evolution, ensuring safety, and unveiling therapeutic potential

Yap, E. C. T. (2023) · International e-Journal of Science Medicine & Education · doi:10.56026/imu.17.3.13 · Cited by 1

Vaccine adjuvants and carriers

Sarthak, S., Pasupuleti, D., Emmanuel, A., Bansal, A., Joshi, D., Patil, S., Bagwe, P., Uddin, M. N., & D’Souza, M. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00022-9 · Cited by 1

Liposomes as vaccine delivery systems

Wang, N., Liu, X., Ma, X., & Wang, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00009-2 · Cited by 2

mRNA vaccines against arthropod-borne orthofaviviruses

Wang, Z., Chi, H., Deng, Y., & Han, X. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0261 · Cited by 1

Exploring Immune Responses through Dynamic Modeling of Cell‐Immune Interactions in Viral Infection and Vaccination

Kim, K. S., Jung, I. H., & Byun, J. H. (2024) · Complexity · doi:10.1155/2024/3357763 · Cited by 1

COVID-19 and Promising Expected Vaccines

Suliman, N. (2021) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000253 · Cited by 1

pDNA and mRNA vaccines

Gill, K., Minall, L., & Nassif, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814357-5.00007-6 · Cited by 1

Novel dendritic cell vaccine strategies

Munson, P. V., Butterfield, L. H., & Adamik, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823901-8.00003-0 · Cited by 1

A New Strategy for Nucleic Acid Delivery and Protein Expression Using Biocompatible Nanohydrogels of Predefined Sizes

Eswaran, L., Kazimirsky, G., Yehuda, R., & Byk, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030961 · Cited by 1

Delivery of Nucleic Acids, Such as siRNA and mRNA, Using Complex Formulations

Pattnaik, A., Pany, S., Sanket, A. S., Das, S., Pati, S., & Samal, S. K. (2022) · Methods and principles in medicinal chemistry · doi:10.1002/9783527827855.ch9 · Cited by 1

Vaccines for SARS coronavirus 2 and the new normal in vaccinology

Griffiths, P. D. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2229

Pencapaian vaksinasi COVID-19 pada anak usia 12 - 18 tahun periode Agustus - September 2021 di Puskesmas Kelurahan Cililitan

Wijayanti, L. K. S. U., Kurniawan, A., Srikandi, A. F., Daniko, J. L., & Kurniawan, S. B. (2021) · Intisari Sains Medis · doi:10.15562/ism.v12i3.1210

mRNA Therapeutics and mRNA Vaccines

Itaka, K. (2021) · TRENDS IN THE SCIENCES · doi:10.5363/tits.26.10_38

mRNA delivery via non-viral carriers for biomedical applications

Shuai, Q., Zhu, F., Zhao, M., & Yan, Y. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121020 · Cited by 35

Nonviral targeted mRNA delivery: principles, progresses, and challenges

He, X., Li, G., Huang, L., Shi, H., Zhong, S., Zhao, S., Jiao, X., Xin, J., Yin, X., Liu, S., et al. (2025) · MedComm · doi:10.1002/mco2.70035 · Cited by 22

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

Wang, Y., Kumari, M., Chen, G., Hong, M.-H., Yuan, J. P., Tsai, J.-L., & Wu, H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00977-5 · Cited by 198

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667

Challenges and advances of the stability of mRNA delivery therapeutics

Zhai, J., Cote, T., & Chen, Y. (2024) · Nucleic Acid Insights · doi:10.18609/nai.2024.015 · Cited by 30